相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease
Shobini Jayaraman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2022)
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100-and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
Dragana Nikolic et al.
DIABETES THERAPY (2021)
Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies
Laura Toma et al.
BIOMEDICINES (2021)
Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
Bruno Verges et al.
DIABETES CARE (2021)
Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion
Corinna Dannecker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
Hang-Long Li et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease
Salman Ul Islam et al.
ANTIOXIDANTS (2021)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages
Nuria Puig et al.
CELLS (2020)
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
Jing-Lu Jin et al.
CARDIOVASCULAR DIABETOLOGY (2020)
A survey on intensity of statin therapy among diabetes mellitus patients in secondary care practice
K. Indira Adiga et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2020)
NADPH Oxidases and Their Role in Atherosclerosis
Anastasia Poznyak et al.
BIOMEDICINES (2020)
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
Ikaro Breder et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
Cecile L. Bandet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
Susanne Schuster et al.
SCIENTIFIC REPORTS (2019)
Future perspectives of the pharmacological management of diabetic dyslipidemia
Angelo Maria Patti et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
Marco Mol et al.
REDOX BIOLOGY (2019)
Management of diabetic dyslipidemia: An update
Ishwarlal Jialal et al.
WORLD JOURNAL OF DIABETES (2019)
Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis
Alexandrina Volobueva et al.
COR ET VASA (2019)
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Manfredi Rizzo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition
Debapriya Basu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Association between insulin resistance and the development of cardiovascular disease
Valeska Ormazabal et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Robert P. Giugliano et al.
CIRCULATION (2018)
Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study
Ian J. Neeland et al.
DIABETOLOGIA (2018)
Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records
QiPing Feng et al.
PLOS MEDICINE (2018)
Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs
Sultan Alouffi et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes
Anais Szpigel et al.
DIABETOLOGIA (2018)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years
Luiz Sergio F. de Carvalho et al.
DIABETES CARE (2018)
Apolipoprotein status in type 2 diabetes mellitus and its complications
Puhong Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis
Shaohua Wang et al.
SCIENTIFIC REPORTS (2017)
Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
Leonore Wigger et al.
CELL REPORTS (2017)
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Amand F. Schmidt et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
Elisenda Climent et al.
SCIENTIFIC REPORTS (2017)
Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges
Mohamed Hassan Elnaem et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2017)
Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
Nobuya Inagaki et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Approach to Statin Use in 2016: an Update
P. Elliott Miller et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
F. Zaccardi et al.
DIABETES OBESITY & METABOLISM (2016)
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
Rishi K. Wadhera et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A. Ference et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population
Molly E. Harmon et al.
PLOS ONE (2016)
Diabetes Dyslipidemia
Jonathan D. Schofield et al.
DIABETES THERAPY (2016)
Diabetes Dyslipidemia
Jonathan D. Schofield et al.
DIABETES THERAPY (2016)
Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes
Tove Fall et al.
DIABETES (2015)
Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes
S. Matthaei et al.
DIABETES OBESITY & METABOLISM (2015)
Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes
B. Bode et al.
DIABETES OBESITY & METABOLISM (2015)
Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study
Charlotte Andersson et al.
DIABETOLOGIA (2015)
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Joost Besseling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism
Junji Kobayashi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al.
LANCET (2015)
Oxidized LDL and NO synthesis-Biomarkers of endothelial dysfunction and ageing
Daniela Gradinaru et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER)
Brendan M. Everett et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
Raymond E. Soccio et al.
CELL METABOLISM (2014)
Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction
Andrew Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes
Dongxu Fu et al.
JOURNAL OF LIPID RESEARCH (2014)
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial
Frederic Dutheil et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis
Rongrong Cai et al.
PLOS ONE (2014)
Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages
Xuxia Sui et al.
PLOS ONE (2014)
Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men
Essam Eldin Mohamed Nour Eldin et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Defect of insulin signal in peripheral tissues: important role of ceramide
Rima Hage Hassan et al.
WORLD JOURNAL OF DIABETES (2014)
D-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation
Pooja Malhotra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Endothelial dysfunction - A major mediator of diabetic vascular disease
Cristina M. Sena et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes
Jose Luis Sanchez-Quesada et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
James Boon et al.
DIABETES (2013)
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy Effect of Baseline Risk Factors for Diabetes
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Small, Dense LDL Particles Predict Changes in Intima Media Thickness and Insulin Resistance in Men with Type 2 Diabetes and Prediabetes - A Prospective Cohort Study
Philipp A. Gerber et al.
PLOS ONE (2013)
Lipoproteínas modificadas como marcadores de riesgo cardiovascular en la diabetes mellitus
José Luis Sánchez-Quesada et al.
Endocrinologia y Nutricion (2013)
Effect of Improving Glycemic Control in Patients With Type 2 Diabetes Mellitus on Low-Density Lipoprotein Size, Electronegative Low-Density Lipoprotein and Lipoprotein-Associated Phospholipase A2 Distribution
Jose L. Sanchez-Quesada et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Statins are diabetogenic - Myth or reality?
Naveed Sattar et al.
ATHEROSCLEROSIS SUPPLEMENTS (2012)
Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy
D. Fu et al.
DIABETOLOGIA (2012)
Ezetimibe therapy: mechanism of action and clinical update
Binh An P. Phan et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL
Laura Toma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Pathways of cholesterol oxidation via non-enzymatic mechanisms
Luigi Iuliano
CHEMISTRY AND PHYSICS OF LIPIDS (2011)
Are statins diabetogenic?
Uchechukwu K. Sampson et al.
CURRENT OPINION IN CARDIOLOGY (2011)
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists A review of their efficacy and tolerability
Alan J. Garber
DIABETES CARE (2011)
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
L. A. Leiter et al.
DIABETES OBESITY & METABOLISM (2011)
Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets
D. Favre et al.
DIABETOLOGIA (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Oxidized Low-Density Lipoprotein Inhibits Nitric Oxide-Mediated Coronary Arteriolar Dilation by Up-regulating Endothelial Arginase I
Wei Wang et al.
MICROCIRCULATION (2011)
Mechanisms of LDL oxidation
Hiroshi Yoshida et al.
CLINICA CHIMICA ACTA (2010)
Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
Naila Rabbani et al.
DIABETES (2010)
Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
M. Rizzo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy
Martina Krueger et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Increased Lipid Peroxidation in LDL from Type-2 Diabetic Patients
Romain Colas et al.
LIPIDS (2010)
The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells
Ling Li et al.
ATHEROSCLEROSIS (2009)
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma
Constantinos C. Tellis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance
Jacob M. Haus et al.
DIABETES (2009)
Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study
Omer T. Njajou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Lipid modification in type 2 diabetes: the role of LDL and HDL
Bruno Verges
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
Philipp Wiesner et al.
JOURNAL OF LIPID RESEARCH (2009)
Dyslipidemia in type 2 diabetes mellitus
Arshag D. Mooradian
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors
Z. Ravid et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Glycation as an atherogenic modification of LDL
Nahla Younis et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
B. Verges et al.
DIABETOLOGIA (2008)
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
Kaspar Berneis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Pharmacological differences of glitazones -: Does peroxisome proliferator-activated receptor-α activation make the difference?
Ulrich Kintscher
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Structural basis for the activation of PPARγ by oxidized fatty acids
Toshimasa Itoh et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability-analysis in hypercholesterolemic rabbits
Seigo Ishino et al.
ATHEROSCLEROSIS (2007)
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
Mark A. Deeg et al.
DIABETES CARE (2007)
Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
Joanna R. Worley et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated
Catherine Calzada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
Masako Tabuchi et al.
JOURNAL OF LIPID RESEARCH (2007)
The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-α in macrophages
Yeshao Wen et al.
ENDOCRINOLOGY (2007)
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study
R. C. Hoogeveen et al.
DIABETOLOGIA (2007)
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control
M. Nakata et al.
DIABETOLOGIA (2006)
Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies
Toshiyuki Hayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein
S Lally et al.
DIABETOLOGIA (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis
B Zhang et al.
JOURNAL OF LIPID RESEARCH (2005)
Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients
T Inukai et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
CG Schalkwijk et al.
CLINICAL SCIENCE (2005)
Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis
Y Takahashi et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCα
I Fleming et al.
CARDIOVASCULAR RESEARCH (2005)
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
VB Ritov et al.
DIABETES (2005)
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
A Ceriello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment
P Libby et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Atherogenic lipoprotein particles in atherosclerosis
R Carmena et al.
CIRCULATION (2004)
Favorable effects of pioglitazone and metformin compared with gliclazoide on lipoprotein subfractions in overweight patients with early type 2 diabetes
JM Lawrence et al.
DIABETES CARE (2004)
Lipids and lipoproteins in patients with type 2 diabetes
RM Krauss
DIABETES CARE (2004)
Peroxisome proliferator-activated receptors and atherogenesis - Regulators of gene expression in vascular cells
N Marx et al.
CIRCULATION RESEARCH (2004)
Glucose enhances endothelial LOX-1 expression - Role for LOX-1 in glucose-induced human monocyte adhesion to endothelium
L Li et al.
DIABETES (2003)
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen
DIABETOLOGIA (2003)
Mitochondrial dysfunction in the elderly: Possible role in insulin resistance
KF Petersen et al.
SCIENCE (2003)
Diabetic LDL triggers apoptosis in vascular endothelial cells
M Artwohl et al.
DIABETES (2003)
Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy
L Duvillard et al.
DIABETES CARE (2003)
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
WT Garvey et al.
DIABETES (2003)
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
VV Kunjathoor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance
S Kopprasch et al.
DIABETES (2002)
Low density lipoprotein can cause death of islet β-cells by its cellular uptake and oxidative modification
M Cnop et al.
ENDOCRINOLOGY (2002)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
M Takemoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Proatherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes -: Impact of the degree of triglyceridemia
M Guérin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
KJ Moore et al.
NATURE MEDICINE (2001)
Structure of low density lipoprotein (LDL) particles:: Basis for understanding molecular changes in modified LDL
T Hevonoja et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time - In vivo insights from stable-isotope studies
J Pietzsch et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Oxidation of LDL by myeloperoxidase and reactive nitrogen species - Reaction pathways and antioxidant protection
AC Carr et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus
L Duvillard et al.
DIABETOLOGIA (2000)
Action of atorvastatin in combined hyperlipidemia - Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles
M Guerin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
